國家衛生研究院 NHRI:Item 3990099045/4507
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 956349      線上人數 : 849
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/4507


    題名: Potential usage of liposome-encapsulated phosphor for in vivo imaging of tissue oxygenation
    作者: Lo, L;Ho, J;Chang, Y;Chang, C;Yang, C
    貢獻者: Division of Medical Engineering Research
    摘要: Oxygen-dependent quenching of phosphorescence can provide a quantitative measurement with high temporal resolution of tissue oxygenation in vivo. It is a real-time optical means for prognosis of diseases where the oxygen concentration is essential. Phosphorescence quenching is a non-invasive methodology, otherwise no more than minimally invasive as the phosphor is necessarily introduced into vasculature prior to the measurement. Oxyphor R2, a dendritic phosphor with two-layer of glutamates, is a suitable phosphor for oxygen measurements owing to its high water solubility. We used a frequency-domain, phase modulation based instrument to calibrate Oxyphor R2. The acquired quenching constant (k<sub>Q</sub>) and lifetime at zero oxygen (τ°) were consistent with those calibrated from conventional time-domain instrument. Administered with Oxyphor R2, the rat hepatic oxygen distributions were imaged throughout the course of ischemia and reperfusion. After 5 min ischemia and subsequent 20 min reperfusion, distinct ischemic areas on the hepatic tissue were observed. In order to extend the application of in vivo oxygen imaging using phosphorescence quenching by minimizing the possible immunoresponse induced by phosphor, we are the first to co-synthesize the dipalmitoylphosphatidylglycerol (DPPG)-rich liposome with Oxyphor R2 to generate the liposome-encapsulated Oxyphor R2. Its calibration using the frequency domain measurement displayed higher quenching constant and shorter lifetime at zero oxygen (k<sub>Q</sub> = 1186 mmHg<sup>-1</sup> sec<sup>-1</sup>; τ° = 150 μsec) comparing to original Oxyphor R2 (k<sub>Q</sub> = 438 mmHg <sup>-1</sup> sec<sup>-1</sup>; τ° = 630 μsec). It implicated that the liposome-encapsulated Oxyphor R2 designed to neutralize the immunoresponse could be further applied to measure the tissue oxygenation in vivo, especially those with low oxygen concentration such as tumor.
    日期: 2004-08
    關聯: Biomedical Engineering - Applications, Basis and Communications. 2004 Aug;16(4):224-232.
    Link to: http://www.worldscinet.com/bme/16/1604/S10162372041604.html
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=8644235831
    顯示於類別:[羅履維] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    SCP8644235831.pdf1420KbAdobe PDF331檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋